Orthopedic surgeons sometimes treat soft tissue tumors, and they sometimes encounter adipocytic tumors that must be diagnosed and treated. A lipoma is a benign tumor that can usually be treated conservatively [1, 7]. Even if the tumor size is large, surgical treatment is not necessary as long as it remains asymptomatic. On the other hand, ALT/WDLS is the most common subtype of liposarcoma, and the treatment for these tumors is controversial [1] because it is reported that 1–4% of them undergo dedifferentiation [23–25] and may become malignant tumors [2, 8, 23, 26]. If preoperative differential diagnosis between ALT/WDLS and lipoma is easy in ALT/WDLS patients, surgical resection is recommended before dedifferentiation [1]. The decision of the resection margin of ALT/WDLS is difficult because the local recurrence rate is high [7]. It has been reported that there was no significant difference in the recurrence rate between the wide and marginal resection in ALT [27], and "conservative" surgery, aiming to preserve major vessels or nerves, may be recommended for deep-seated ALT/WDLS [28–31]. However, insufficient resection may increase the risk of recurrence and dedifferentiation and resulting in the need for more surgery to perform additional tissue resection. We have reported studies on treatment strategies for ALT/WDLS [29], and based on the results, if the border between the normal tissue and ALT/WDLS of the limb is ill-defined, sub-extensive resection is performed including the surrounding soft tissue, such as muscle tissue. If the border is well-defined between such a tumor and neurovascular bundles, marginal resection and sub-extensive resection are performed. On the other hand, in recent years, Vos et al. reported that observation could be a reasonable option for selected patients with extremity WDLS [32]. For these reasons, it is crucial to make an accurate differential diagnosis between ALT/WDLS and lipoma for the preoperative plan of the appropriate resection margin and the appropriate selection of patients who can be observed.
For the differential diagnosis, previous studies reported critical factors such as clinical findings (older age [13, 33, 34], tumor size [> 10cm] [1, 12, 33, 35], tumor site [lower extremity] [12, 33, 35], and deep-seated location [1]) and MRI findings (thick septa [> 2mm] [17, 18], fat content less than 75% [34], and contrast enhancement [1]).
In this study, a multivariate analysis was performed to evaluate the predictive factors for ALT/WDLS. There was a significant difference in tumor site (lower extremity), depth, size (> 11cm), thick septa, and enhancement of septa or nodular lesions. All of these were consistent with the previously mentioned factors, demonstrating high accuracy for the differential diagnosis of ALT/WDLS. MRI findings have high sensitivity but low specificity for the diagnosis of ALT/WDLS, and it has been reported that it may be difficult to decide the diagnosis of them by only MRI findings [7, 33]. On the other hand, Brisson et al. reported that histopathological examination could be used to distinguish ALT/WDLS from lipomas [33], so for adipocytic tumors, needle biopsies have been generally performed preoperatively to obtain the diagnosis [2].
Histopathological findings in the multivariate analysis showed that lipoblasts were statistically significant for the diagnosis of ALT/WDLS. Traditionally, lipoblasts have been emphasized as a histopathological finding in the diagnosis of liposarcoma [36]. However, lipoblasts are also observed in benign lipogenic tumors such as spindle cell/pleomorphic lipoma. Furthermore, it has been reported that they are not always observed in ALT/WDLS [37]. Although the diagnostic accuracy of lipoblasts in the diagnosis of ALT/WDLS has not been clarified, our study revealed that their sensitivity was low (19.6%), but the specificity was very high (98.9%). In the combined scoring system, it is implied that lipoblasts are crucial findings for the diagnosis of ALT/WDLS.
In this study, nuclear atypia had a significant difference in the differential diagnosis of ALT/WDLS by univariate analysis. ALT/WDLS features a mature adipocytic tumor showing atypical hyperchromatic nuclei [2], which is consistent with our results. No nuclear atypia is found in lipoma, which is a benign tumor, so this characteristic is used for the rule out of the diagnosis of these tumors. The specificity of nuclear atypia was 100% in the diagnosis of ALT/WDLS in this study. However, needle biopsies may not provide enough sample for the identification of unequivocal atypical cells [7, 38], and the atypical stromal cells sometimes scatter throughout the lesion; therefore, in some cases, the difference between ALT/WDLS and lipoma may be subtle challenging the differential diagnosis process [38]. In addition, FISH examination for MDM2 and CDK4 gene amplification has provided the most accuracy for the diagnosis of ALT/WDLS [9–13, 15, 16], and it is considered the gold standard for the differential diagnosis between ALT/WDLS and lipoma [15]. In this study, as well as previous studies, MDM2 and/or CDK4 amplification by FISH examination showed a significant difference as a predictive factor for ALT/WDLS. Furthermore, the specificity was 100%. MDM2 gene amplification in FISH examination has high sensitivity and specificity [15], and this finding has been used for the definitive diagnosis of ALT/WDLS. However, similar to nuclear atypia, an insufficient sample and the selection of an inappropriate needle biopsy site might complicate the accurate exclusion of a diagnosis of ALT/WDLS due to the absence of MDM2 gene amplification. Furthermore, HE staining in the histopathological examination can be generally performed in many institutions, but FISH examination requires special equipment and reagents, which not all institutions are equipped to perform [7]. For these reasons, this study excluded the nuclear atypia and FISH examination used for the definitive diagnosis of ALT/WDLS and aimed to develop a scoring system for the differential diagnosis of ALT/WDLS in case where these factors were negative.
Therefore, in adipocytic tumors, the differential diagnosis should be evaluated based on a comprehensive assessment of clinical, radiological, and histopathological examinations. Although a few scoring systems for the differential diagnosis of ALT/WDLS based on radiological findings have been reported [1, 7], there is no diagnostic scoring system that includes histopathological findings. Here, we aimed to develop a new combined scoring system, including clinical, radiological, and histopathological findings, to easily perform the preoperative differential diagnosis between ALT/WDLS and lipoma.
A combined scoring system with 6 predictive factors for ALT/WDLS that had a significant difference in multivariate analysis was developed. The total points of this scoring system were 16 points, and the ROC curve analysis showed a sensitivity of 87.6%, a specificity of 91.1%, and an AUC of 0.945 in the diagnosis of ALT/WDLS. The cutoff value was 9 points, and the possibility of ALT/WDLS increased as the total score increased.
In the previous studies of similar scoring systems, Nagano et al. reported a sensitivity of 100% and specificity of 77% [1], and Cheng et al. reported a sensitivity of 90% and specificity of 92.5% [7]. The diagnostic accuracy for ALT/WDLS of this scoring system is almost the same as in these studies. However, Nagano et al. study examined 48 lipomas and 12 ALTs, without including WDLS, and the case number was lower compared with our study [1]. Although this study investigated adipocytic tumors in all locations, Cheng et al. investigated only deep-seated adipocytic tumors [7]. These limitations may have affected the difference in accuracy between our scoring system and those studies.
In this study, our combined scoring system could not improve FISH for MDM2 in ALT/WDLS. Although high sensitivity and specificity of FISH for MDM2 in ALT/WDLS have been reported in previous studies, FISH for MDM2 and has been performed in limited institutions. This scoring system may help to differentiate between lipoma and ALT/WDLS in cases without the assessment of MDM2 amplification.
The histopathological findings included in this scoring system are based on the specimens of preoperative needle biopsy. Therefore, this is a limitation of this study because the evaluation of these specimens may be affected by the biopsy site and the amount of sample, and not all medical institutions can perform a needle biopsy. If needle biopsy cannot be performed, our scoring system can use 5 predictive factors except lipoblast and the cutoff value was 10 points in total 13 points. Since the cutoff value of this scoring system including lipoblast was 9 points, a needle biopsy may be recommended in the case of 6–8 points in the scoring system except for lipoblast. Furthermore, if a preoperative needle biopsy can be performed with an accurate procedure, the diagnostic accuracy for ALT/WDLS of this scoring system may be higher, which makes it a very useful diagnostic tool for the preoperative differential diagnosis of adipocytic tumors.